OverviewSuggest Edit

Smith & Nephew is a medical technology company. It operates in three main segments: Orthopaedic Reconstruction and Trauma, Endoscopy and Advanced Wound Management. The company offers sports medicine joint repair products for surgeons, arthroscopic enabling technologies for healthcare providers, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, electromechanical and mechanical tissue resection devices, etc. 

TypePublic
Founded1856
HQUS
Websiteglobal.smith-nephew.com

Latest Updates

Employees (est.) (Dec 2017)15,000
Job Openings352
Revenue (FY, 2018)£3.7 B(+3%)
Share Price (May 2020)£1.7 K

Key People/Management at Smith & Nephew

Roland Diggelmann

Roland Diggelmann

Chief Executive Officer
Dave Illingworth

Dave Illingworth

Chief Executive Officer
Olivier Bohuon

Olivier Bohuon

CEO
Graham Baker

Graham Baker

Chief Financial Officer
Vinita Bali

Vinita Bali

Independent Non-Executive Director
Adrian Hennah

Adrian Hennah

Chief Financial Officer
Show more

Smith & Nephew Office Locations

Smith & Nephew has offices in Andover, Austin, Durham, Fort Worth and in 2 other locations
São Paulo, BR
Av. do Café, 277
Andover, US
150 Minuteman Rd
Austin, US
7000 W William Cannon Dr
Durham, US
Carlisle Place, 4721 Emperor Blvd #100
Fort Worth, US
3909 Hulen St
Saint Petersburg, US
970 Lake Carillon Dr #110
Show all (7)

Smith & Nephew Financials and Metrics

Smith & Nephew Revenue

Embed Graph
View revenue for all periods
Smith & Nephew's revenue was reported to be £3.72 b in FY, 2018 which is a 2.9% increase from the previous period.
GBP

Revenue (FY, 2018)

3.7b

Revenue growth (FY, 2017 - FY, 2018), %

2.9%

Gross profit (FY, 2018)

2.7b

Gross profit margin (FY, 2018), %

73.5%

Net income (FY, 2018)

502.7m

EBITDA (FY, 2018)

838.6m

EBIT (FY, 2018)

654.4m

Market capitalization (21-May-2020)

14.6b

Closing stock price (21-May-2020)

1.7k

Cash (31-Dec-2018)

276.8m

EV

14.5b
Smith & Nephew's current market capitalization is £14.6 b.
GBPFY, 1996FY, 1997FY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

1.1b1.0b1.1b1.1b1.1b1.1b1.1b1.2b1.2b1.4b1.4b2.0b2.9b3.2b3.6b3.4b3.6b3.7b

Revenue growth, %

(2%)1%6%1%(5%)3%6%6%13%1%43%11%13%(5%)7%3%

Cost of goods sold

472.6m446.1m453.3m479.6m456.8m350.2m329.9m345.1m334.8m361.0m1.1b600.7m724.8m797.5m883.4m923.3m946.3m984.2m

Gross profit

596.6m602.0m600.1m640.3m677.9m731.5m780.0m833.8m913.7m1.0b292.0m1.4b2.1b2.4b2.7b2.5b2.7b2.7b
GBPFY, 1996FY, 1997FY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

80.5m57.1m49.9m100.5m24.6m30.0m22.5m26.0m32.6m88.0m177.0m102.7m90.3m63.8m92.8m72.6m128.1m276.8m

Accounts Receivable

218.7m219.9m233.1m241.8m246.2m224.4m222.6m246.0m273.5m323.0m322.0m468.3m616.1m664.3m751.3m717.2m800.7m837.1m

Inventories

229.8m225.7m242.4m237.6m228.2m232.2m229.5m230.6m284.9m355.0m316.0m504.0m662.8m810.5m940.6m903.0m988.8m1.1b

Current Assets

564.5m561.3m570.9m619.2m530.6m525.4m532.7m591.1m679.3m937.0m840.0m1.2b1.5b1.7b1.9b1.8b2.1b2.3b
GBPFY, 1996FY, 1997FY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

120.7m113.7m93.7m104.8m205.2m129.6m112.1m148.1m125.2m170.0m201.0m191.0m366.3m343.8m316.9m569.1m581.6m502.7m

Cash From Operating Activities

189.3m181.7m161.9m198.1m204.0m191.9m209.3m214.5m226.6m147.0m190.0m264.7m571.3m468.7m796.1m616.3m826.5m705.9m

Dividends Paid

66.5m69.0m69.2m72.5m456.9m42.9m44.6m46.1m47.8m50.0m49.0m62.8m157.5m164.0m202.5m195.3m

Cash From Financing Activities

40.4m(19.7m)158.7m17.8m94.8m(93.1m)(16.9m)(22.0m)(196.0m)209.7m(328.1m)691.8m(431.3m)(384.0m)(329.1m)(281.3m)
GBPY, 2018

EV/EBITDA

17.2 x

EV/EBIT

22.1 x

EV/CFO

20.5 x

Financial Leverage

1.7 x
Show all financial metrics

Smith & Nephew Operating Metrics

Smith & Nephew's Training Provided, no. of people was reported to be 90 k in FY, 2016.
FY, 2016

Training Provided, no. of people

90 k
Show all operating metrics

Smith & Nephew Acquisitions / Subsidiaries

Company NameDateDeal Size
Osiris TherapeuticsMarch 15, 2019$600 m

Smith & Nephew Revenue Breakdown

Embed Graph

Smith & Nephew revenue breakdown by business segment: 12.9% from Sports Medicine Joint Repair , 13.9% from Arthroscopic Enabling Technologies , 9.9% from Trauma & Extremities, 19.8% from Knee Implants, 12.9% from Hip Implants, 14.9% from Advanced Wound Care, 6.9% from Advanced Wound Bioactives and 8.9% from Other

Smith & Nephew Online and Social Media Presence

Embed Graph

Smith & Nephew News and Updates

London Markets: Smith & Nephew stands out in otherwise struggling London stock market

London stocks struggled for direction on Thursday, as investors assessed fresh coronavirus risk, with Smith & Nephew PLC standing out with gains after upbeat results.

Emerging markets help Smith & Nephew beat annual sales record

Improved underlying revenue growth of 4.4 per cent has propelled Smith & Nephew’s sales above $5bn (£3.8bn) for the first [...] The post Emerging markets help Smith & Nephew beat annual sales record appeared first on CityAM.

Global Artificial Disc Replacement Market Report 2019 by Technology and Top Companies- Alphatec Spine, Medtronic, De Puy Spine, Stryker, Smith & Nephew and more...

A new market study, titled “Global Artificial Disc Replacement Market Report 2019 - Market Size, Share, Price, Trend and Forecast”, has been featured on WiseGuyReports. Posted via Industry Today. Follow us on Twitter @IndustryToday

Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc

COLUMBIA, Md., April 17, 2019 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, announced today that it has completed the previously announced sale of Osiris t…

Smith & Nephew teases next-gen surgical robotics platform

Smith & Nephew has acquired Brainlab‘s orthopedic joint reconstruction business and teased the unveiling of a next-generation surgical robotics platform for later in 2019. The London-based company said that its acquisition of Brainlab’s orthopaedic joint reconstruction business included its asso…

UPDATE 1-Britain's Smith & Nephew to buy Osiris in regenerative products push

Smith & Nephew Plc said on Tuesday it would buy U.S.-based regenerative medicine maker Osiris Therapeutics for $660 million, as the British medical products maker looks to bulk up in an area that is quickly growing.
Show more

Smith & Nephew Frequently Asked Questions

  • When was Smith & Nephew founded?

    Smith & Nephew was founded in 1856.

  • Who are Smith & Nephew key executives?

    Smith & Nephew's key executives are Roland Diggelmann, Dave Illingworth and Olivier Bohuon.

  • How many employees does Smith & Nephew have?

    Smith & Nephew has 15,000 employees.

  • What is Smith & Nephew revenue?

    Latest Smith & Nephew annual revenue is £3.7 b.

  • What is Smith & Nephew revenue per employee?

    Latest Smith & Nephew revenue per employee is £247.9 k.

  • Who are Smith & Nephew competitors?

    Competitors of Smith & Nephew include Integer Holdings, Stryker and Sonova.

  • Where are Smith & Nephew offices?

    Smith & Nephew has offices in Andover, Austin, Durham, Fort Worth and in 2 other locations.

  • How many offices does Smith & Nephew have?

    Smith & Nephew has 7 offices.